Research To Practice | Oncology Videos Acute Myeloid Leukemia | Striving for Consensus on the Management of Secondary Acute Myeloid Leukemia
May 31, 2022
02:18:34
A clinical investigator think tank and enduring multimedia activity with Drs Naval Daver, Stephen Strickland, Geoffrey Uy and Eunice Wang, including the following topics:
- Introduction to therapy-related Acute Myeloid Leukemia (AML) (0:00)
- Treatment of AML evolving from prior MDS (12:27)
- Treatment of secondary AML in a patient ineligible for intensive therapy (29:41)
- Treatment for a patient with secondary AML with an IDH mutation (40:56)
- Long-term follow-up of CPX- 351 in patients with secondary AML (46:27)
- Potential role of venetoclax in combination with intensive chemotherapy regimens (52:54)
- Treatment for younger patients with secondary AML (58:46)
- Treatment of secondary AML with a FLT3 mutation (1:03:59)
- Data with CPX-351 in combination with targeted agents (1:08:30)
- Refractory disease versus differentiation syndrome from IDH inhibitors (1:19:20)
- Emerging data with menin inhibitors (1:28:13)
- Treatment of secondary AML evolving from prior MPN (1:31:52)
- Treatment of secondary AML with core binding factor (1:53:14)